TWC
RPTX

TD Waterhouse Canada’s Repare Therapeutics RPTX Stock Holding History

TD Waterhouse Canada’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,250
Closed -$3.25K – 2387
2025
Q4 		$3.25K Hold
1,250
– – ﹤0.01% 1764
2025
Q3 		$2.23K Hold
1,250
– – ﹤0.01% 1813
2025
Q2 		$1.77K Hold
1,250
– – ﹤0.01% 1742
2025
Q1 		$1.26K Hold
1,250
– – ﹤0.01% 1727
2024
Q4 		$1.64K Hold
1,250
– – ﹤0.01% 1728
2024
Q3 		$4.33K Hold
1,250
– – ﹤0.01% 1523
2024
Q2 		$4.14K Hold
1,250
– – ﹤0.01% 1528
2024
Q1 		$5.38K Hold
1,250
– – ﹤0.01% 1520
2023
Q4 		$8.84K Hold
1,250
– – ﹤0.01% 1280
2023
Q3 		$14.6K Hold
1,250
– – ﹤0.01% 1149
2023
Q2 		$13.2K Hold
1,250
– – ﹤0.01% 1189
2023
Q1 		$12K Hold
1,250
– – ﹤0.01% 1190
2022
Q4 		$16.9K Hold
1,250
– – ﹤0.01% 1125
2022
Q3 		$15.7K Hold
1,250
– – ﹤0.01% 1157
2022
Q2 		$17.3K Hold
1,250
– – ﹤0.01% 1142
2022
Q1 		$18K Hold
1,250
– – ﹤0.01% 1195
2021
Q4 		$26.2K Buy
+1,250
New +$29.4K ﹤0.01% 1152

TD Waterhouse Canada's RPTX Position: Q1 2026 in Review

TD Waterhouse Canada sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 1,250 shares — an estimated $3.25K sold.

TD Waterhouse Canada first reported a position in RPTX in Q4 2021 and held it in 17 quarters. The position peaked at $26.2K in Q4 2021. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

  • TD Waterhouse Canada reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
  • TD Waterhouse Canada sold 1,250 Repare Therapeutics shares in Q1 2026, an estimated $3.25K.
  • TD Waterhouse Canada first reported a position in Repare Therapeutics in Q4 2021 and held it in 17 quarters.
  • TD Waterhouse Canada's Repare Therapeutics position peaked at $26.2K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.